Should I consider a second autologous stem cell transplant?

FAQ Library published on December 13, 2017
Download Transcript Download Audio
Saad Z. Usmani, MD, FACP
Chief, Plasma Cell Disorders Program
Director, Clinical Research in Hematologic Malignancies
Levine Cancer Institute/Atrium Health
Charlotte, North Carolina
Clinical Professor of Medicine, UNC-Chapel Hill School of Medicine
Chapel Hill, North Carolina

Welcome to Managing Myeloma, I am Dr. Saad Usmani. I am frequently asked, “Should I consider a second autologous stem cell transplant (ASCT) for my patient?” When you ask that question you also have to ask, “How did my patient do with the first autologous stem cell transplant?” Did they tolerate it well? Did they have any significant comorbidities after the autologous stem cell transplant that required a long duration of recovery? Then, what kind of progression-free survival (PFS) benefit did the patient get from that first autologous stem cell transplant? If they got an ASCT and then did not receive any maintenance afterwards, one would consider a good PFS to be at least 18-24 months, preferably more. In the setting of lenalidomide maintenance, I would probably push that threshold closer to 24-36 months or more, going by the median PFS benefit that we would expect to get for those patients. If the answer is yes to any of those questions, then yes, we should be considering a second autologous stem cell transplant for our patients in the early relapse setting. Thank you for viewing this activity

Last modified: November 2, 2017
Related Items by Author
Can I use a patient’s previous regimen again as salvage?
Saad Z. Usmani, MD, FACP
FAQ Library published on November 8, 2017
What is the ideal follow-up of MGUS and smoldering multiple myeloma patients?
Saad Z. Usmani, MD, FACP
FAQ Library published on May 10, 2017
What Should Be Included in the Diagnostic Work-up of MM Patients?
Saad Z. Usmani, MD, FACP
FAQ Library published on March 8, 2017
What is the role of gene expression profiling in multiple myeloma? How can it help in taking care of myeloma patients in a better way?
Saad Z. Usmani, MD, FACP
FAQ Library published on October 12, 2015